The Medicines Company
Quick facts
Marketed products
- Placebo (D5W)
D5W (dextrose 5% in water) is an intravenous fluid that provides hydration and a modest amount of glucose for energy.
Phase 3 pipeline
- Angiomax (bivalirudin) · Cardiovascular
Bivalirudin is a direct thrombin inhibitor that binds to and blocks thrombin, preventing blood clot formation. - Standard of Care IV antihypertensive · Cardiovascular
Blocks the action of angiotensin II at its receptor, leading to vasodilation and decreased blood pressure.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about The Medicines Company
What are The Medicines Company's marketed drugs?
Top marketed products include Placebo (D5W).
What is The Medicines Company's pipeline?
The Medicines Company has 2 drugs in Phase 3, 2 in Phase 2, 2 in Phase 1. Late-stage candidates include Angiomax (bivalirudin), Standard of Care IV antihypertensive.
Related
- Placebo (D5W)
- Sector hub: All tracked pharma companies